About Imis Pharmaceuticals Private Limited
Data last updated:
Imis Pharmaceuticals Private Limited is a private limited company based in Vijayawada (Urban), Andhra Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 25 June 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP1981PTC003079. Its GSTIN is 37AAACI4786L1Z1 (Andhra Pradesh). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was formerly known as Imis Pharmaceuticals Pvt Ltd. It is led by directors including Naga Lakshmi Vepakomma (Managing Director) and Nagamallika Gudipaty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 30 – 17 – 1 Seetharampuramvijayawada – 520 002, Vijayawada (Urban), Andhra Pradesh, India – 520002.
As per the financials filed for FY 2022, the company reported a revenue of ₹10.35 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹11.24 Lakh (net margin 1.1%) and EBITDA of ₹1.85 Cr (EBITDA margin 17.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 13% over five years.
The company has about 158 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.76 Cr and satisfied charges of ₹1.13 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website imispharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address30 – 17 – 1 Seetharampuramvijayawada – 520 002, Vijayawada (Urban), Andhra Pradesh, India – 520002
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Imis Pharmaceuticals Private Limited FY 2025 filings available
Imis Pharmaceuticals Private Limited reported revenue of ₹10.35 Cr (up 36% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Imis Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 36% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Imis Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹10.35 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.85 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.24 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Imis Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Imis Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals Private Limited is audited by RAJESWAR & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESWAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naga Lakshmi Vepakomma | Managing Director | 01 Apr 1998 | 28 Years 6 Months | Current |
| Nagamallika Gudipaty | Director | 12 Jun 2015 | 11 Years 3 Months | Current |
| Nagaprasuna Balantrapu | Director | 04 Aug 2017 | 9 Years 2 Months | Current |
| Dubagunta Nagasaila Also directs: Barefoot Change Associates Private Limited | Director | 12 Jun 2015 | 11 Years 3 Months | Current |
Ownership and Shareholding of Imis Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Imis Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2009 | Indian Overseas Bank | ₹2.76 Cr | Open |
| 15 Dec 2008 | Andhra Bank | ₹30 Lakh | Satisfied |
| 20 Jan 2005 | Andhra Bank | ₹6.5 Lakh | Satisfied |
| 28 May 2004 | Andhra Bank | ₹18 Lakh | Satisfied |
| 29 Dec 1994 | Andhra Bank | ₹5 Lakh | Satisfied |
Total charge records: 9 View all charges
Legal Cases of Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals Private Limited has 5 court cases on record: 4 filed by Imis Pharmaceuticals, 1 filed against it. 1 case is pending and 4 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 2 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Union of India | Pending |
| District court, Krishna, Andhra Pradesh | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, Krishna, Andhra Pradesh | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, Krishna, Andhra Pradesh | Civil suit | Filed by the company against Govind Pharma | Disposed |
| High Court of Gujarat | Court case (AO) | Filed against the company by Akshay Traders | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals Private Limited has a workforce of 158 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals Private Limited has 8 board changes on record since 1998: 4 appointments and 4 cessations. The latest: Naga Lakshmi Vepakomma ceased to be Director on 22 Aug 2020.
21 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Imis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Imis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Imis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAACI4786L1Z1 | Andhra Pradesh | Active | 01 Jul 2017 |
| 29AAACI4786L1ZY | Karnataka | Active | 01 Nov 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Imis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imis Pharmaceuticals Private Limited
Imis Pharmaceuticals is an active private limited company based in Vijayawada (Urban), Andhra Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 25 June 1981 (45+ years old) and is registered under CIN U24239AP1981PTC003079.
Imis Pharmaceuticals reported revenue of ₹10.35 Cr for FY 2022 (up 36% YoY).
Imis Pharmaceuticals has 4 current directors:
- Naga Lakshmi Vepakomma - Managing Director
- Nagamallika Gudipaty - Director
- Nagaprasuna Balantrapu - Director
- Dubagunta Nagasaila - Director
Imis Pharmaceuticals reported a net profit of ₹11.24 Lakh (net margin 1.1%) and EBITDA of ₹1.85 Cr (EBITDA margin 17.9%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Imis Pharmaceuticals is 20% over three years and 13% over five years. In the latest year (FY 2022) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Imis Pharmaceuticals is 37AAACI4786L1Z1, registered in Andhra Pradesh. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAACI4786L1ZY (Karnataka).
The CIN (Corporate Identification Number) of Imis Pharmaceuticals is U24239AP1981PTC003079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imis Pharmaceuticals has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Imis Pharmaceuticals was incorporated on 25 June 1981, making it 45+ years old. It is registered with the Registrar of Companies, Vijayawada.
Naga Lakshmi Vepakomma ceased to be Director on 22 Aug 2020. Krishna Vepakomma ceased to be Director on 13 Jan 2019. Dubagunta Indumathi ceased to be Director on 04 Aug 2017. Imis Pharmaceuticals has 8 board changes on record in total.